Mir-29b, in turn, typically negatively regulates Dnmt3b, a DNA methyltransferase, with the expression of DNMT3B found to be elevated in primary LGLL patient cells. This evidence concerns the gene DNMT3B and T-cell large granular lymphocyte leukemia.